Invention Grant
- Patent Title: Fusion protein
- Patent Title (中): 融合蛋白
-
Application No.: US12503468Application Date: 2009-07-15
-
Publication No.: US08309096B2Publication Date: 2012-11-13
- Inventor: Normand Blais , Martine Boyer , Vincent Brichard , Jamila Louahed , Denis Martin , Remi Palmantier , Clement Rioux
- Applicant: Normand Blais , Martine Boyer , Vincent Brichard , Jamila Louahed , Denis Martin , Remi Palmantier , Clement Rioux
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals S.A.
- Current Assignee: GlaxoSmithKline Biologicals S.A.
- Current Assignee Address: BE Rixensart
- Agent Eric J. Kron
- Priority: GB0700759.4 20070115; GB0709707.4 20070521
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K38/00 ; C07K1/00
Abstract:
Fusion proteins comprising an antigen derived from NY-ESO-1 linked to an antigen derived from LAGE-1, which may further comprise carriers, fusion partners, or the like, are provided. Methods for preparing, formulating, and using such fusion proteins are also provided. Such proteins are useful a vaccine components for inducing an immune response against a range of cancer-antigen-bearing cells.
Public/Granted literature
- US20100029912A1 Fusion Protein Public/Granted day:2010-02-04
Information query
